Loading institutional data...
Loading institutional data...
Held by 576 of 2,417 reporting institutions (99th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Ranked against 29 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TMO | $262.2B | 40.0× | 33.5× | 5.9× | 3.9% | — | 15.0% | 12.6% | 7.0% | 3.7× | 953 |
| KLAC | $218.5B | 45.8× | — | 16.1× | 11.7% | 61.3% | 35.6% | 76.1% | 39.5% | — | 751 |
| DHR | $163.3B | 46.0× | 33.4× | 6.7× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 700 |
| ISRG | $158.5B | 57.0× | 43.8× | 15.8× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | -0.9× | 693 |
| MDT | $124.2B | 26.0× | 15.9× | 3.4× | 8.4% | 65.0% | 13.2% | 9.7% | 6.2% | 2.8× | 748 |
| SYK | $119.6B | 37.1× | 20.4× | 4.8× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 1.8× | 738 |
| TT | $94.9B | 33.2× | 23.4× | 4.5× | 7.5% | — | 13.7% | 34.0% | 22.1% | 0.7× | 570 |
| MMM | $91.5B | 29.6× | 17.5× | 3.7× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 788 |
| NOC | $79.9B | 19.3× | 15.2× | 1.9× | 2.2% | — | 10.0% | 25.1% | 12.9% | 1.9× | 576 |
| BSX | $60.8B | 21.6× | 11.9× | 3.0× | 19.9% | 69.0% | 14.4% | 11.9% | 11.8% | -0.3× | 407 |
| KEYS | $56.2B | 67.2× | 56.4× | 10.4× | 8.0% | 62.1% | 15.8% | 14.5% | 10.1% | 0.7× | 354 |
| AME | $55.3B | 37.7× | 27.8× | 7.5× | 6.6% | 36.0% | 20.0% | 13.9% | 11.5% | 0.9× | 337 |
| GRMN | $53.9B | 32.6× | 25.5× | 7.5× | 15.1% | 58.7% | 23.0% | 18.5% | 18.5% | -1.1× | 324 |
| BDX | $53.9B | 34.0× | 14.4× | 2.5× | 8.2% | 45.4% | 7.7% | 6.6% | 3.8% | 3.7× | 458 |
| EW | $53.0B | 50.3× | 35.7× | 8.7× | 11.5% | 78.0% | 17.7% | 10.4% | 9.8% | -1.6× | 399 |
| ROK | $50.1B | 58.9× | 26.1× | 6.0× | 0.9% | 48.1% | 10.4% | 23.8% | 12.6% | 1.4× | 464 |
| A | $49.3B | 38.3× | 28.8× | 7.1× | 6.7% | 52.4% | 18.8% | 19.3% | 12.9% | 0.9× | 357 |
| WAT | $47.1B | 44.6× | 53.3× | 14.9× | 7.0% | 59.3% | 20.3% | 25.1% | 18.3% | 0.4× | 360 |
| TER | $46.3B | 85.4× | 59.4× | 14.5× | 13.1% | 58.2% | 17.4% | 19.8% | 18.5% | -0.1× | 385 |
| ROP | $44.5B | 31.7× | 17.1× | 5.6× | 12.3% | 69.2% | 19.4% | 7.7% | 5.3% | 2.9× | 303 |
| ILMN | $43.8B | 53.2× | 40.7× | 10.1× | -0.7% | 66.1% | 19.6% | 31.2% | 31.2% | 0.0× | 308 |
| COHR | $41.4B | 51.0× | — | 5.8× | 22.5% | 37.5% | 11.3% | 7.4% | 5.7% | — | 334 |
| RMD | $35.6B | 24.2× | 16.6× | 6.3× | 9.9% | 61.1% | 26.9% | 23.1% | 21.0% | -0.4× | — |
| GEHC | $34.6B | 16.8× | 13.1× | 1.7× | 4.8% | 40.0% | 10.1% | 20.1% | 10.2% | 1.8× | 356 |
| MTD | $34.4B | 40.9× | 33.8× | 8.6× | 4.0% | 59.4% | 21.6% | — | 40.8% | 2.0× | 195 |
Peers = companies sharing NOC's sector (Search, Detection, Navigation, Guidance, Aeronautical Sys) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $557.54 today, the market must believe free cash flow compounds 7.8%/yr for a decade (off $2.68B on the 3-yr avg basis).
On the basis ($2.57B) the requirement is 8.3%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 7.8% is more optimistic than its 9-yr track record.
Default is 7.1% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.14B shares (market data) · net debt $11.29B
mean 10.2% · volatility σ 30% · implied rate exceeded in 5/9 yrs
Central path = implied 7.8%/yr growth; shaded band = ±1σ (30%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 39% of free cash flow, leaving room to grow it and fund buybacks. Last year: $1.29B dividends + $1.62B buybacks = $2.92B returned on $3.31B FCF.
9 consecutive years of dividend increases · 11%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Modest payoff on reinvested capital. Current ROIC on all capital: 13%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $4.40B covers the $534.0M due within a year 8.2× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~4.2% on $15.70B of debt.
Cash of $4.40B fully covers short-term debt of $534.0M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.95B 100.0% | $41.03B 100.0% | $39.29B 100.0% | $36.60B 100.0% | $35.67B 100.0% | $36.80B 100.0% | $33.84B 100.0% | $30.09B 100.0% | $26.00B 100.0% | $24.71B 100.0% |
| Cost of Revenue | — | — | — | — | — | — | — | — | $12.27B 47.2% | $11.00B 44.5% |
| Cost of Products | — | — | — | — | — | — | — | — | $12.27B 47.2% | $11.00B 44.5% |
| Cost of Services | — | — | — | — | — | — | — | — | $7.58B 29.1% | $7.73B 31.3% |
| Research & Development | $1.10B 2.6% | $1.10B 2.7% | $1.20B 3.1% | $1.20B 3.3% | $1.10B 3.1% | $1.10B 3.0% | $953.0M 2.8% | $764.0M 2.5% | $639.0M 2.5% | $705.0M 2.9% |
| Selling, General & Admin | $4.03B 9.6% | $3.99B 9.7% | $4.01B 10.2% | $3.87B 10.6% | $3.60B 10.1% | $3.41B 9.3% | $3.29B 9.7% | $3.01B 10.0% | $2.71B 10.4% | $2.63B 10.7% |
| Total Operating Expenses | $37.67B 89.8% | $36.66B 89.4% | $36.75B 93.5% | $33.00B 90.2% | $32.00B 89.7% | $32.73B 89.0% | $29.87B 88.3% | — | — | — |
| Operating Income | $4.51B 10.8% | $4.37B 10.6% | $2.54B 6.5% | $3.60B 9.8% | $5.65B 15.8% | $4.07B 11.0% | $3.97B 11.7% | $3.78B 12.6% | $3.22B 12.4% | $3.28B 13.3% |
| Interest Expense | $665.0M 1.6% | $621.0M 1.5% | $545.0M 1.4% | $506.0M 1.4% | $556.0M 1.6% | $593.0M 1.6% | $528.0M 1.6% | $562.0M 1.9% | $360.0M 1.4% | $301.0M 1.2% |
| Other Income (Expense), net | $154.0M 0.4% | $168.0M 0.4% | $246.0M 0.6% | $4.0M 0.0% | $19.0M 0.1% | $92.0M 0.3% | $107.0M 0.3% | $130.0M 0.4% | $136.0M 0.5% | $44.0M 0.2% |
| Pretax Income | $5.07B 12.1% | $5.02B 12.2% | $2.35B 6.0% | $5.84B 15.9% | $8.94B 25.1% | $3.73B 10.1% | $2.55B 7.5% | $3.74B 12.4% | $4.23B 16.3% | $2.68B 10.9% |
| Income Tax Expense | $886.0M 2.1% | $842.0M 2.1% | $290.0M 0.7% | $940.0M 2.6% | $1.93B 5.4% | $539.0M 1.5% | $300.0M 0.9% | $513.0M 1.7% | $1.36B 5.2% | $638.0M 2.6% |
| Net Income | $4.18B 10.0% | $4.17B 10.2% | $2.06B 5.2% | $4.90B 13.4% | $7.00B 19.6% | $3.19B 8.7% | $2.25B 6.6% | $3.23B 10.7% | $2.87B 11.0% | $2.04B 8.3% |
| Per Share | ||||||||||
| EPS (Basic) | $29.14 | $28.39 | $13.57 | $31.61 | $43.70 | $19.08 | $13.28 | $18.59 | $16.45 | $11.42 |
| EPS (Diluted) | $29.08 | $28.34 | $13.53 | $31.47 | $43.54 | $19.03 | $13.22 | $18.49 | $16.34 | $11.32 |
| Weighted Avg Shares (Basic) | 143.5M | 147.0M | 151.5M | 154.9M | 160.3M | 167.1M | 169.3M | 173.7M | 174.4M | 178.9M |
| Weighted Avg Shares (Diluted) | 143.8M | 147.3M | 152.0M | 155.6M | 160.9M | 167.6M | 170.0M | 174.6M | 175.6M | 180.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 75th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 25% against ROIC 13% — 12% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 26.2% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.4× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| R&D | 2.5 | 2.8 | 3.0 | 3.1 | 3.3 | 3.1 | 2.7 | 2.6 |
| SG&A | 10.0 | 9.7 | 9.3 | 10.1 | 10.6 | 10.2 | 9.7 | 9.6 |
| Operating Income | 12.6 | 11.7 | 11.0 | 15.8 | 9.8 | 6.5 | 10.6 | 10.8 |
| Income Tax | 1.7 | 0.9 | 1.5 | 5.4 | 2.6 | 0.7 | 2.1 | 2.1 |
| Net Income | 10.7 | 6.6 | 8.7 | 19.6 | 13.4 | 5.2 | 10.2 | 10.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on NOC: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns 4.54pts above its cost of capital, but net margin has stepped down from 1337.63% to 996.81% over 3 years.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 14.8% | 7.2% (today's — no rate published for this year) | 7.6pts |
| FY2020 | 14.9% | 7.2% (today's — no rate published for this year) | 7.8pts |
| FY2021 | 19.3% | 5.0% | 14.3pts |
| FY2022 | 10.7% | 6.7% | 4.0pts |
| FY2023 | 7.5% | 6.4% | 1.1pts |
| FY2024 | 12.2% | 6.8% | 5.5pts |
| FY2025 | 12.3% | 6.4% | 5.9pts |
| Now | 12.9% | 7.2% | 5.8pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 55.5% | 13.3% | 8.3% |
| FY2017 | 52.8% | 12.4% | 11.0% |
| FY2018 | not reported | 12.6% | 10.7% |
| FY2019 | not reported | 11.7% | 6.6% |
| FY2020 | not reported | 11.0% | 8.7% |
| FY2021 | not reported | 15.8% | 19.6% |
| FY2022 | not reported | 9.8% | 13.4% |
| FY2023 | not reported | 6.5% | 5.2% |
| FY2024 | not reported | 10.7% | 10.2% |
| FY2025 | not reported | 10.8% | 10.0% |
Leverage and buybacks account for 12 points of the 25% return on equity in FY2025. The business earns 13% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$17.4B of goodwill — 54% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer. With goodwill over half the base, the ex-goodwill figure divides by a small remainder and moves sharply — read it as a direction, not a precise rate.
ROIC ex-goodwill is 25.15% against 11.69% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Cash conversion of 0.61x sits below the level that would make the earnings clearly cash-backed.
The cash conversion cycle could not be computed — receivables, inventory or cost of revenue is not reported — so the earliest accrual warning is not part of this verdict.
Covers interest 4.7x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 6.78x |
| 5% | 6.44x |
| 10% | 6.11x |
| 15% | 5.77x |
| 20% | 5.43x |
| 25% | 5.09x |
| 30% | 4.75x |
| 35% | 4.41x |
| 40% | 4.07x |
| 45% | 3.73x |
| 50% | 3.39x |
| 55% | 3.05x |
| 60% | 2.71x |
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $562.36, free cash flow must compound 8.21%/yr for 10 years. It has done 1.45%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | −4.9% | 8.2% |
| FY2021 | −25.4% | 8.2% |
| FY2022 | −31.9% | 8.2% |
| FY2023 | 43.2% | 8.2% |
| FY2024 | 24.8% | 8.2% |
| FY2025 | 26.2% | 8.2% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The implied rate has been matched or beaten in 3 of the last 6 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $4.18B | $4.18B |
| Share-based comp | $119M | $4.30B |
| Other non-cash & working capital | $456M | $4.76B |
| Operating cash flow | $4.76B | $4.76B |
| Capex | −$1.45B | $3.31B |
| Free cash flow | $3.31B | $3.31B |
| FCF after SBC | $3.19B | $3.19B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 8.7% | 13.2% | 4.5 points |
| FY2021 | -3.1% | -2.3% | 0.8 points |
| FY2022 | 2.6% | 3.0% | 0.4 points |
| FY2023 | 7.3% | -3.8% | -11.1 points |
| FY2024 | 4.4% | -12.5% | -17.0 points |
| FY2025 | 2.2% | 8.1% | 5.9 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 14.3 days | not reported | not reported | not reported |
| FY2020 | 14.9 days | not reported | not reported | not reported |
| FY2021 | 15 days | not reported | not reported | not reported |
| FY2022 | 15.1 days | not reported | not reported | not reported |
| FY2023 | 13.5 days | not reported | not reported | not reported |
| FY2024 | 11.3 days | not reported | not reported | not reported |
| FY2025 | 12 days | not reported | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -5.0 percent |
| FY2020 | -2.5 percent |
| FY2021 | 8.1 percent |
| FY2022 | 4.6 percent |
| FY2023 | -3.9 percent |
| FY2024 | -0.4 percent |
| FY2025 | -1.1 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 1 year to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-30 | Brown Marianne Catherine Director | Grant | 96 | $483.48 | $46k |
| 2026-09-30 | Krishna Arvind Director | Grant | 75 | $483.48 | $36k |
| 2026-08-19 | Warden Kathy J Chair, CEO and President | Grant | 35,910 | $0.00 | — |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 8 |
| $544.53 |
| $4k |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale | 19 | $545.59 | $10k |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale | 11 | $546.42 | $6k |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale | 31 | $547.42 | $17k |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale | 10 | $548.32 | $5k |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale | 6 | $549.50 | $3k |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale | 2 | $550.68 | $1k |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale | 2 | $552.95 | $1k |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale | 2 | $553.90 | $1k |
| 2026-08-03 | 10 co-filers Group filing | 10b5-1 plan sale | 4 | $554.14 | $2k |
| 2026-06-30 | Brown Marianne Catherine Director | Grant | 91 | $509.31 | $46k |
| 2026-06-30 | Krishna Arvind Director | Grant | 71 | $509.31 | $36k |
| 2026-05-20 | Winston Mary A Director | Grant | 349 | $552.17 | $193k |
| 2026-05-20 | Welsh Mark A Iii Director | Grant | 349 | $552.17 | $193k |
| 2026-05-20 | Turley James S Director | Grant | 349 | $552.17 | $193k |
| 2026-05-20 | Schoewe Thomas M Director | Grant | 349 | $552.17 | $193k |
| 2026-05-20 | Roughead Gary Director | Grant | 349 | $552.17 | $193k |
| 2026-05-20 | Ross Kimberly A. Director | Grant | 349 | $552.17 | $193k |
| 2026-05-20 | Krishna Arvind Director | Grant | 349 | $552.17 | $193k |
| 2026-05-20 | Grady Christopher W. Director | Grant | 349 | $552.17 | $193k |
| 2026-05-20 | Brown Marianne Catherine Director | Grant | 349 | $552.17 | $193k |
| 2026-05-20 | Abney David P Director | Grant | 349 | $552.17 | $193k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 1 | $566.60 | $567 |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 5 | $568.75 | $3k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 9 | $569.49 | $5k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 43 | $570.47 | $25k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 3 | $571.74 | $2k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 6 | $572.72 | $3k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 14 | $573.51 | $8k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 2 | $574.51 | $1k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 4 | $575.59 | $2k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 7 | $576.38 | $4k |
| 2026-05-04 | 11 co-filers Group filing | 10b5-1 plan sale | 1 | $577.05 | $577 |
| 2026-03-31 | Krishna Arvind Director | Grant | 53 | $682.24 | $36k |
| 2026-03-31 | Brown Marianne Catherine Director | Grant | 68 | $682.24 | $46k |
| 2026-03-02 | Simpson Kathryn G Corp VP & General Counsel | 10b5-1 plan sale | 873 | $745.00 | $650k |
| 2026-02-27 | Roeder Roshan S CVP & Pres. Mission Systems | 10b5-1 plan sale | 1,754 | $720.00 | $1.3m |